 AUSTIN, TX ACCESSWIRE June 14, 2021 Apollo Endosurgery, Inc. Apollo NASDAQ:APEN, a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced that investigators of the Multi-Center ESG Randomized Interventional MERIT study have reported based on a preliminary analysis the successful achievement of the studys primary endpoints. In a presentation at the 2021 Surgical Disruptive Technologies Summit meeting in Houston, Texas, Dr. Barham Abu Dayyeh, Professor of Medicine and Director of Advanced Endoscopy at the Mayo Clinic, commented, I am very pleased to report that, in a preliminary analysis, the MERIT study comparing the Endoscopic Sleeve Gastroplasty ESG procedure to medically supervised moderate intensity lifestyle modification has achieved its primary endpoints for both efficacy and safety. 